Patient and disease characteristics: GC versus non-GC
. | GC cases . | . | Non-GC cases . | . | ||
|---|---|---|---|---|---|---|
. | No. . | % . | No. . | % . | ||
| Total patients | 28 | 32 | 60 | 68 | ||
| AAIPI | ||||||
| Low | 3 | 11 | 12 | 20 | ||
| Low-Intermediate | 7 | 25 | 12 | 20 | ||
| High-Intermediate | 12 | 43 | 21 | 35 | ||
| High | 6 | 21 | 15 | 25 | ||
| LDH | ||||||
| Normal | 12 | 43 | 24 | 40 | ||
| Elevated | 16 | 57 | 36 | 60 | ||
| KPS | ||||||
| ≥ 80 | 18 | 64 | 41 | 68 | ||
| < 80 | 10 | 36 | 19 | 32 | ||
| Stage | ||||||
| I/II | 5 | 18 | 16 | 27 | ||
| III/IV | 23 | 82 | 44 | 73 | ||
| Age | ||||||
| ≤ 60 | 21 | 75 | 53 | 88 | ||
| > 60 | 7 | 25 | 7 | 12 | ||
| Extranodal sites | ||||||
| < 2 | 14 | 50 | 39 | 65 | ||
| ≥ 2 | 14 | 50 | 21 | 35 | ||
| Previous response | ||||||
| Relapse | 14 | 50 | 34 | 57 | ||
| Refractory | 14 | 50 | 26 | 43 | ||
| EFS (GC vs non-GC), P = .52 | 28/7 | 25 | 60/18 | 29 | ||
| OS (GC vs non-GC), P = .68 | 28/11 | 35 | 60/22 | 38 | ||
| ICE response | ||||||
| CR/PR | 22 | 79 | 43 | 72 | ||
| Failure | 6 | 21 | 17 | 28 | ||
| EFS/ASCT, P = .52 | 22/7 | 32 | 43/18 | 40 | ||
| OS/ASCT, P = .94 | 22/11 | 50 | 43/21 | 51 | ||
| Response to transplant | ||||||
| CR/PR | 15 | 54 | 27 | 45 | ||
| Failure | 4 | 14 | 10 | 17 | ||
| Relapse after transplant | 10 | 36 | 17 | 28 | ||
. | GC cases . | . | Non-GC cases . | . | ||
|---|---|---|---|---|---|---|
. | No. . | % . | No. . | % . | ||
| Total patients | 28 | 32 | 60 | 68 | ||
| AAIPI | ||||||
| Low | 3 | 11 | 12 | 20 | ||
| Low-Intermediate | 7 | 25 | 12 | 20 | ||
| High-Intermediate | 12 | 43 | 21 | 35 | ||
| High | 6 | 21 | 15 | 25 | ||
| LDH | ||||||
| Normal | 12 | 43 | 24 | 40 | ||
| Elevated | 16 | 57 | 36 | 60 | ||
| KPS | ||||||
| ≥ 80 | 18 | 64 | 41 | 68 | ||
| < 80 | 10 | 36 | 19 | 32 | ||
| Stage | ||||||
| I/II | 5 | 18 | 16 | 27 | ||
| III/IV | 23 | 82 | 44 | 73 | ||
| Age | ||||||
| ≤ 60 | 21 | 75 | 53 | 88 | ||
| > 60 | 7 | 25 | 7 | 12 | ||
| Extranodal sites | ||||||
| < 2 | 14 | 50 | 39 | 65 | ||
| ≥ 2 | 14 | 50 | 21 | 35 | ||
| Previous response | ||||||
| Relapse | 14 | 50 | 34 | 57 | ||
| Refractory | 14 | 50 | 26 | 43 | ||
| EFS (GC vs non-GC), P = .52 | 28/7 | 25 | 60/18 | 29 | ||
| OS (GC vs non-GC), P = .68 | 28/11 | 35 | 60/22 | 38 | ||
| ICE response | ||||||
| CR/PR | 22 | 79 | 43 | 72 | ||
| Failure | 6 | 21 | 17 | 28 | ||
| EFS/ASCT, P = .52 | 22/7 | 32 | 43/18 | 40 | ||
| OS/ASCT, P = .94 | 22/11 | 50 | 43/21 | 51 | ||
| Response to transplant | ||||||
| CR/PR | 15 | 54 | 27 | 45 | ||
| Failure | 4 | 14 | 10 | 17 | ||
| Relapse after transplant | 10 | 36 | 17 | 28 | ||